Trump, executive order and pharma industry price cuts
Digest more
AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity. Here’s how to do it.
Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not lower prices
By Chioma Obinna The Director-General of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof Mojisola Adeyeye, has called for a strategic partnership between Nigeria’s pharmaceutical industry and academic institutions to enhance local development of medicines and vaccines,
Latin Times on MSN1d
RFK Jr. Admitting Big Pharma Paid Trump '$100 Million' Leaves Internet Stunned: 'Was That a Fraudian Slip?'RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.
Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank approvals if drugmakers do not lower prices.
President Donald Trump on Monday signed an executive order reviving a controversial plan to lower prescription drug costs by linking the price of certain medications in the U.S. to their lower prices in other countries.
Antibiotics, antidepressants and other drugs frequently leach into the environment, where they can impact ecosystems and human health.
The company then offers to sell or analyze that de-identified information for its clients in the pharmaceutical industry. In the other model, the clinic is a subsidiary of the company collecting ...
The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations to push industry talking points in Washington and across the nation.
Feedback